Testing effectiveness (Phase 2)Looking for participantsNCT07476794
What this trial is testing
Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma
Who this might be right for
Glioblastoma
Sunnybrook Health Sciences Centre 118